Randomized Clinical Trial for the Optimization of Dyslipidemia Management in Patients with End-Stage Renal Disease Undergoing In-Hospital Maintenance Hemodialysis Therapy

<b>Background/Objectives</b>: End-stage renal disease (ESRD) patients on maintenance hemodialysis (MHD) frequently develop L-carnitine (LC) deficiency, leading to dyslipidemia and increased cardiovascular risk. While LC supplementation may improve dyslipidemia, the optimal route of administration re...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Sadia Rehman, Muhammad Farhan, Muhammad Raza Sarfraz, Asma Naveed, Fahad Usman, Anila Bibi, Raheel Ahmed, Hiya Huq, Ali Hasan, Jarin Anzoom, Pobitro Kumar
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	MDPI AG 2025-08-01
Seri Bilgileri:	Pharmaceutics
Konular:	hemodialysis renal replacement therapy carnitine acetylcarnitine hyperlipidemias
Online Erişim:	https://www.mdpi.com/1999-4923/17/9/1128
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!